Read more about BBCR’s Streamlined Clinical Development Strategies in DigiTech Insight
Tagged: Boston Biotech Clinical Research
We are excited about the recognition by the DIGITECH insight magazine that included the BBCR’s proprietary SCIO process within the top 10 innovations in drug development for 2022.
February 9th, 2022 | Boston Biotech Clinical Research
BBCR uses innovative approaches to de-risk your product development. For our clients interested in Proof of Mechanism and Proof of Concept – PoM and PoC – BBCR has the expertise to ensure successful product development at any stage of development.
February 2nd, 2022 | Boston Biotech Clinical Research
The BBCR team designs Proof of Concept (PoC) Trials and Proof of Mechanism (PoM) studies with the drug clinical plan and regulatory strategy in mind. Proof of Mechanism (PoM) Usually in Healthy Volunteers, Phase 1 study Essential for the selection of appropriate dose for PoC, disease model and biomarkers Investigate drug concentration at the target […]
BBCR’s team expertise in rare diseases and precision medicine, combined with SCIO approach, helps streamline trials for swift regulatory approvals. For our clients, this ensures that the proper focus is given to cost containment and value-based developments that allow sponsors to move more treatments to market faster.
December 16th, 2021 | Boston Biotech Clinical Research
BBCR provides expert market guidance and embraces innovative strategy consulting for effective clinical development plan and regulatory strategy. Developing drugs for rare diseases and precision medicine indications can be rewarding, but navigating the challenges is not for the faint of heart. Expert guidance is essential in an area where the patients are few, lack of […]
BBCR works with clients beyond consulting, to create cost-effective clinical trials and strategies that nurture product strengths
November 11th, 2021 | Boston Biotech Clinical Research
Streamlined Clinical Development Strategies Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. […]
BBCR offers expertise in the areas of Product Development Planning and Validation or Qualification when biomarkers are a part of your product development plan.
October 26th, 2021 | Boston Biotech Clinical Research
Boston Biotech Clinical Research specializes in rare disease, working with biotech, pharmaceutical, device companies and investors to help streamline the clinical trial process.
October 20th, 2021 | Boston Biotech Clinical Research
Understanding how a Strategic Clinical Innovation Organization can help streamline the clinical trial process.
October 13th, 2021 | Boston Biotech Clinical Research
BBCR offers streamlined clinical development and clinical and regulatory expertise to a variety of clients both domestically and internationally.
October 6th, 2021 | Boston Biotech Clinical Research
The BBCR team of experts has worked in pre-clinical and clinical product development and regulatory affairs. We believe that understanding the perspective, challenges, and needs of our clients allows us to serve as a trusted adviser throughout the clinical development process. BBCR clients are domestic and international drug and device biotechnology firms as well as […]
BBCR embraces innovative strategy consulting for effective clinical development plan and regulatory strategy. Reach out today to learn more about how we can help advance your project.
September 15th, 2021 | Boston Biotech Clinical Research
Our industry needs innovative strategies, and reduced-risk clinical trials. BBCR clinical development services and drug development consulting integrates real world evidence into clinical development plans and regulatory strategies. Focus must go to cost containment and value-based developments that allow sponsors to move more treatments to market faster. BBCR’s team expertise in rare diseases and precision […]
The most efficient path in the clinical research process is a moving target. Biotech innovation and regulatory requirements require constant monitoring. Through BBCR Voice, we aim to share not only our knowledge and expertise, but also solutions to current challenges in the regulatory and research environments.
August 5th, 2021 | Boston Biotech Clinical Research
BBCR is dedicated to meeting the challenges of developers and investors seeking a clearer path to market. We invite you to bookmark our blog page and follow us across social media to keep abreast of timely and relevant topics in our industry.